Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana

Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals and is endemic in Africa, parts of South America and southern Asia. The causative agent, FMD virus (FMDV) is a member of the genus Aphthovirus, family Picornaviridae. Vaccines currently used against FMDV are chemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Veerapen, Varusha Pillay, Van Zyl, Albertha R., Wigdorovitz, Andres, Rybicki, Edward P., Meyers, Ann E.
Formato: info:eu-repo/semantics/article
Lenguaje:Inglés
Publicado: 2018
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/2154
https://www.sciencedirect.com/science/article/pii/S0168170217306573?via%3Dihub#!
https://doi.org/10.1016/j.virusres.2017.11.027
_version_ 1855034913758117888
author Veerapen, Varusha Pillay
Van Zyl, Albertha R.
Wigdorovitz, Andres
Rybicki, Edward P.
Meyers, Ann E.
author_browse Meyers, Ann E.
Rybicki, Edward P.
Van Zyl, Albertha R.
Veerapen, Varusha Pillay
Wigdorovitz, Andres
author_facet Veerapen, Varusha Pillay
Van Zyl, Albertha R.
Wigdorovitz, Andres
Rybicki, Edward P.
Meyers, Ann E.
author_sort Veerapen, Varusha Pillay
collection INTA Digital
description Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals and is endemic in Africa, parts of South America and southern Asia. The causative agent, FMD virus (FMDV) is a member of the genus Aphthovirus, family Picornaviridae. Vaccines currently used against FMDV are chemically inactivated virus strains which are produced under high-level biocontainment facilities, thus raising their cost. The development of recombinant FMDV vaccines has focused predominantly on FMDV virus-like particle (VLP) subunit vaccines for which promising results have been achieved. These VLPs are attractive candidates because they avoid the use of live virus in production facilities, but conserve the complete repertoire of conformational epitopes of the virus. Recombinant FMDV VLPs are formed by the expression and assembly of the three structural proteins VP0, VP1 and VP3. This can be attained by co-expression of the three individual structural capsid proteins or by coexpression of the viral capsid precursor P1-2A together with the viral protease 3C. The latter proteolytically cleaves P1-2A into the respective structural proteins. These VLPS are produced in mammalian or insect cell culture systems, which are expensive and can be easily contaminated. Plants, such as Nicotiana benthamiana, potentially provide a more cost-effective and very highly scalable platform for recombinant protein and VLP production. In this study, P1-2A was transiently expressed in N. benthamiana alone, without the 3C protease. Surprisingly, there was efficient processing of the P1-2A polyprotein into its component structural proteins, and subsequent assembly into VLPs. The yield was ∼0.030 μg per gram of fresh leaf material. Partially purified VLPs were preliminarily tested for immunogenicity in mice and shown to stimulate the production of FMDV-specific antibodies. This study, has important implications for simplifying the production and expression of potential vaccine candidates against FMDV in plants, in the absence of 3C expression.
format info:eu-repo/semantics/article
id INTA2154
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2018
publishDateRange 2018
publishDateSort 2018
record_format dspace
spelling INTA21542018-06-21T15:00:37Z Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana Veerapen, Varusha Pillay Van Zyl, Albertha R. Wigdorovitz, Andres Rybicki, Edward P. Meyers, Ann E. Fiebre Aftosa Nicotiana Vacuna Virus Foot and Mouth Disease Vaccines Viruses Nicotiana benthamiana Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals and is endemic in Africa, parts of South America and southern Asia. The causative agent, FMD virus (FMDV) is a member of the genus Aphthovirus, family Picornaviridae. Vaccines currently used against FMDV are chemically inactivated virus strains which are produced under high-level biocontainment facilities, thus raising their cost. The development of recombinant FMDV vaccines has focused predominantly on FMDV virus-like particle (VLP) subunit vaccines for which promising results have been achieved. These VLPs are attractive candidates because they avoid the use of live virus in production facilities, but conserve the complete repertoire of conformational epitopes of the virus. Recombinant FMDV VLPs are formed by the expression and assembly of the three structural proteins VP0, VP1 and VP3. This can be attained by co-expression of the three individual structural capsid proteins or by coexpression of the viral capsid precursor P1-2A together with the viral protease 3C. The latter proteolytically cleaves P1-2A into the respective structural proteins. These VLPS are produced in mammalian or insect cell culture systems, which are expensive and can be easily contaminated. Plants, such as Nicotiana benthamiana, potentially provide a more cost-effective and very highly scalable platform for recombinant protein and VLP production. In this study, P1-2A was transiently expressed in N. benthamiana alone, without the 3C protease. Surprisingly, there was efficient processing of the P1-2A polyprotein into its component structural proteins, and subsequent assembly into VLPs. The yield was ∼0.030 μg per gram of fresh leaf material. Partially purified VLPs were preliminarily tested for immunogenicity in mice and shown to stimulate the production of FMDV-specific antibodies. This study, has important implications for simplifying the production and expression of potential vaccine candidates against FMDV in plants, in the absence of 3C expression. Inst.de Virología Fil: Veerapen, Varusha Pillay. University of Cape Town. Department of Molecular and cell Biology. Biopharming Research Unit; Sudáfrica Fil: Van Zyl, Albertha R. University of Cape Town. Department of Molecular and cell Biology. Biopharming Research Unit; Sudáfrica Fil: Wigdorovitz, Andres. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Rybicki, Edward P. University of Cape Town. Department of Molecular and cell Biology. Biopharming Research Unit; Sudáfrica. University of Cape Town. Faculty of Health Sciences. Institute of Infectious Disease and Molecular Medicine; Sudáfrica Fil: Meyers, Ann E. University of Cape Town. Department of Molecular and cell Biology. Biopharming Research Unit; Sudáfrica 2018-04-03T15:27:33Z 2018-04-03T15:27:33Z 2018-01 info:eu-repo/semantics/article info:ar-repo/semantics/artículo info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/2154 https://www.sciencedirect.com/science/article/pii/S0168170217306573?via%3Dihub#! 0168-1702 https://doi.org/10.1016/j.virusres.2017.11.027 eng info:eu-repo/semantics/restrictedAccess application/pdf Virus research 244 : 213-217. (January 2018)
spellingShingle Fiebre Aftosa
Nicotiana
Vacuna
Virus
Foot and Mouth Disease
Vaccines
Viruses
Nicotiana benthamiana
Veerapen, Varusha Pillay
Van Zyl, Albertha R.
Wigdorovitz, Andres
Rybicki, Edward P.
Meyers, Ann E.
Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title_full Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title_fullStr Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title_full_unstemmed Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title_short Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
title_sort novel expression of immunogenic foot and mouth disease virus like particles in nicotiana benthamiana
topic Fiebre Aftosa
Nicotiana
Vacuna
Virus
Foot and Mouth Disease
Vaccines
Viruses
Nicotiana benthamiana
url http://hdl.handle.net/20.500.12123/2154
https://www.sciencedirect.com/science/article/pii/S0168170217306573?via%3Dihub#!
https://doi.org/10.1016/j.virusres.2017.11.027
work_keys_str_mv AT veerapenvarushapillay novelexpressionofimmunogenicfootandmouthdiseaseviruslikeparticlesinnicotianabenthamiana
AT vanzylalberthar novelexpressionofimmunogenicfootandmouthdiseaseviruslikeparticlesinnicotianabenthamiana
AT wigdorovitzandres novelexpressionofimmunogenicfootandmouthdiseaseviruslikeparticlesinnicotianabenthamiana
AT rybickiedwardp novelexpressionofimmunogenicfootandmouthdiseaseviruslikeparticlesinnicotianabenthamiana
AT meyersanne novelexpressionofimmunogenicfootandmouthdiseaseviruslikeparticlesinnicotianabenthamiana